Abnormal brain function of the rat neonate in a prenatal 5-bromo-2'-deoxyuridine (BrdU)-induced developmental disorder model

International Journal of Developmental Neuroscience

Volumn 30, Issue 6, 2012, Pages 507-515

  Ogawa, Tetsuo ^a   Kuwagata, Makiko ^a,b   Muneoka, Katsumasa ^a   Wakai, Chizu ^a   Senuma, Mika ^b   Kubo, Hiroko ^a   Shioda, Seiji ^a  

^a SHOWA UNIVERSITY   (Japan)

^b HATANO RESEARCH INSTITUTE   (Japan)

Author keywords

BrdU; C Fos; Developmental neurotoxicity; Home cage deprivation; Pre weaning examination

Indexed keywords

BROXURIDINE; PROTEIN C FOS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; BEHAVIOR DISORDER; BRAIN DYSFUNCTION; CELL COUNT; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; EXPERIMENTATION; FEMALE; HOME CAGE DEPRIVATION; HYPERACTIVITY; IMMUNOREACTIVITY; LEARNING DISORDER; LOCUS CERULEUS; MALE; MATERNAL DEPRIVATION; MEMORY DISORDER; NEWBORN; NONHUMAN; PRENATAL DEVELOPMENT; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGENY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PYRIFORM CORTEX; RAT;

ANIMALS; ANIMALS, NEWBORN; ANTIMETABOLITES; BRAIN; BROMODEOXYURIDINE; DEVELOPMENTAL DISABILITIES; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; SOCIAL ISOLATION;

RATTUS;

EID: 84865860723     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2012.05.002     Document Type: Article

References (40)

1. Bambini-Junior V., Rodrigues L., Behr G.A., Moreira J.C., Riesgo R., Gottfried C. Animal model of autism induced by prenatal exposure to valproate: behavioral changes and liver parameters. Brain Research 2011, 1408:8-16.
2. Baraldi M., Zanoli P., Rossi T., Borella P., Caselgrandi E., Petraglia F. Neurobehavioral and neurochemical abnormalities of pre- and postnatally lead-exposed rats: zinc, copper and calcium status. Neurobehavioral Toxicology and Teratology 1985, 7(5):499-509.
3. Carpenter D.O. Effects of metals on the nervous system of humans and animals. International Journal of Occupational Medicine and Environmental Health 2001, 14(3):209-218.
4. Chen S.W., Shemyakin A., Wiedenmayer C.P. The role of the amygdala and olfaction in unconditioned fear in developing rats. Journal of Neuroscience 2006, 26(1):233-240.
5. Dellu-Hagedorn F. Spontaneous individual differences in cognitive performances of young adult rats predict locomotor response to amphetamine. Neurobiology of Learning and Memory 2005, 83(1):43-47.
6. Dufour-Rainfray D., Vourc'h P., Le Guisquet A.M., Garreau L., Ternant D., Bodard S., Jaumain E., Gulhan Z., Belzung C., Andres C.R., Chalon S., Guilloteau D. Behavior and serotonergic disorders in rats exposed prenatally to valproate: a model for autism. Neuroscience Letters 2010, 470(1):55-59.
7. Ferguson J.N., Aldag J.M., Insel T.R., Young L.J. Oxytocin in the medial amygdala is essential for social recognition in the mouse. Journal of Neuroscience 2001, 21(20):8278-8285.
8. Huizink A.C., Mulder E.J. Maternal smoking, drinking or cannabis use during pregnancy and neurobehavioral and cognitive functioning in human offspring. Neuroscience and Biobehavioral Reviews 2006, 30(1):24-41.
9. Ingram J.L., Peckham S.M., Tisdale B., Rodier P.M. Prenatal exposure of rats to valproic acid reproduces the cerebellar anomalies associated with autism. Neurotoxicology and Teratology 2000, 22(3):319-324.
10. Itoi K., Sugimoto N. The brainstem noradrenergic systems in stress, anxiety and depression. Journal of Neuroendocrinology 2010, 22(5):355-361.
11. Jacobson J.L., Jacobson S.W. Intellectual impairment in children exposed to polychlorinated biphenyls in utero. New England Journal of Medicine 1996, 335(11):783-789.
12. Kim S.K., Moon H.J., Park J.H., Lee G., Shin M.K., Hong M.C., Bae H., Jin Y.H., Min B.I. The maintenance of individual differences in the sensitivity of acute and neuropathic pain behaviors to electroacupuncture in rats. Brain Research Bulletin 2007, 74(5):357-360.
13. Kuwagata M., Muneoka K.T., Ogawa T., Takigawa M., Nagao T. Locomotor hyperactivity following prenatal exposure to 5-bromo-2'-deoxyuridine: neurochemical and behavioral evidence of dopaminergic and serotonergic alterations. Toxicology Letters 2004, 152(1):63-71.
14. Kuwagata M., Nagao T. Behavior and reproductive function of rat male offspring treated prenatally with 5-bromo-2'-deoxyuridine. Reproductive Toxicology 1998, 12(5):541-549.
15. Kuwagata M., Ogawa T., Muneoka K., Shioda S. Hyperactivity induced by prenatal BrdU exposure across several experimental conditions. Congenital Anomalies (Kyoto) 2011, 51(4):177-182.
16. Kuwagata M., Ogawa T., Nagata T., Shioda S. The evaluation of 22 early embryonic neurogenesis after exposure to the genotoxic agent 23 5-bromo-2'-deoxyuridine in mice. Neurotoxicology 2007, 28(4):780-789.
17. Loganovsky K.N., Loganovskaja T.K. Schizophrenia spectrum disorders in persons exposed to ionizing radiation as a result of the Chernobyl accident. Schizophrenia Bulletin 2000, 26(4):751-773.
18. Mattson S.N., Crocker N., Nguyen T.T. Fetal alcohol spectrum disorders: neuropsychological and behavioral features. Neuropsychology Review 2011, 21(2):81-101.
19. Mercugliano M., Hyman S.L., Batshaw M.L. Behavioral deficits in rats with minimal cortical hypoplasia induced by methylazoxymethanol acetate. Pediatrics 1990, 85(3 Pt 2):432-436.
20. Mick E., Biederman J., Faraone S.V., Sayer J., Kleinman S. Case-control study of attention-deficit hyperactivity disorder and maternal smoking, alcohol use, and drug use during pregnancy. Journal of the American Academy of Child and Adolescent Psychiatry 2002, 41(4):378-385.
21. Moore S.J., Turnpenny P., Quinn A., Glover S., Lloyd D.J., Montgomery T., Dean J.C. A clinical study of 57 children with fetal anticonvulsant syndromes. Journal of Medical Genetics 2000, 37(7):489-497.
22. Moriceau S., Roth T.L., Sullivan R.M. Rodent model of infant attachment learning and stress. Developmental Psychobiology 2010, 52(7):651-660.
23. Moriceau S., Wilson D.A., Levine S., Sullivan R.M. Dual circuitry for odor-shock conditioning during infancy: corticosterone switches between fear and attraction via amygdala. Journal of Neuroscience 2006, 26(25):6737-6748.
24. Morris S.M. The genetic toxicology of 5-bromodeoxyuridine in mammalian cells. Mutation Research 1991, 258(2):161-188.
25. Neophytou S.I., Aspley S., Butler S., Beckett S., Marsden C.A. Effects of lesioning noradrenergic neurones in the locus ceruleus on conditioned and unconditioned aversive behaviour in the rat. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2001, 25(6):1307-1321.
26. Ogawa T., Kuwagata M., Muneoka K.T., Shioda S. Neuropathological examination of fetal rat brain in the 5-bromo-2'-deoxyuridine-induced neurodevelopmental disorder model. Congenital Anomalies (Kyoto) 2005, 45(1):14-20.
27. Orito K., Morishima A., Ogawa T., Muneoka K., Kuwagata M., Takata J., Mishima K., Fujiwara M. Characteristic behavioral anomalies in rats prenatally exposed to 5-bromo-2'-deoxyuridine. International Journal of Developmental Neuroscience 2009, 27(1):81-86.
28. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1986, Academic Press.
29. Raineki C., Pickenhagen A., Roth T.L., Babstock D.M., McLean J.H., Harley C.W., Lucion A.B., Sullivan R.M. The neurobiology of infant maternal odor learning. Brazilian Journal of Medical and Biological Research 2010, 43(10):914-919.
30. Raineki C., Shionoya K., Sander K., Sullivan R.M. Ontogeny of odor-LiCl vs. odor-shock learning: similar behaviors but divergent ages of functional amygdala emergence. Learning and Memory 2009, 16(2):114-121.
31. Rogan W.J., Gladen B.C., Hung K.L., Koong S.L., Shih L.Y., Taylor J.S., Wu Y.C., Yang D., Ragan N.B., Hsu C.C. Congenital poisoning by polychlorinated biphenyls and their contaminants in Taiwan. Science 1988, 241(4863):334-336.
32. Schneider T., Przewlocki R. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology 2005, 30(1):80-89.
33. Sevelinges Y., Gervais R., Messaoudi B., Granjon L., Mouly A.M. Olfactory fear conditioning induces field potential potentiation in rat olfactory cortex and amygdala. Learning and Memory 2004, 11(6):761-769.
34. Shionoya K., Moriceau S., Lunday L., Miner C., Roth T.L., Sullivan R.M. Development switch in neural circuitry underlying odor-malaise learning. Learning and Memory 2006, 13(6):801-808.
35. Shipley M.T., Ennis M., Poche A.C. Olfactory system. The Rat Nervous System 2004, 923-964. Elsevier, Inc., California. G. Paxinos (Ed.).
36. Sills T.L., Crawley J.N. Individual differences in sugar consumption predict amphetamine-induced dopamine overflow in nucleus accumbens. European Journal of Pharmacology 1996, 303(3):177-181.
37. Sullivan R.M. Unique characteristics of neonatal classical conditioning: the role of the amygdala and locus ceruleus. Integrative Physiological and Behavioral Science 2001, 36(4):293-307.
38. U.S. EPA, 1998. U.S. Environmental Protection Agency Health Effects Test Guidelines. OPPTS 870.6300. Developmental Neurotoxicity Study. EPA Document 712-C-98-239, U.S. Environmental Protection Agency, Washington, DC.
39. Wiedenmayer C.P., Barr G.A. Developmental changes in c-fos expression to an age-specific social stressor in infant rats. Behavioural Brain Research 2001, 126(1-2):147-157.
40. Williams G., King J., Cunningham M., Stephan M., Kerr B., Hersh J.H. Fetal valproate syndrome and autism: additional evidence of an association. Developmental Medicine and Child Neurology 2001, 43(3):202-206.